Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02380768 · ClinicalTrials.gov registry record · NA
A Comparison of the Ambu AuraGain Versus LMA Supreme in Children
A NA study, sponsored by Ann & Robert H Lurie Children's Hospital of Chicago.
- Completed
- Registry status
- NA
- Development phase
- 100
- Enrollment target
NCT02380768 is a NA study that has completed, run by Ann & Robert H Lurie Children's Hospital of Chicago. The registered enrollment target is 100 participants.
The verdict
NCT02380768, a NA study, has completed, sponsored by Ann & Robert H Lurie Children's Hospital of Chicago.
- COMPLETED
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether there is a clinically relevant difference in airway leak pressures between the Ambu AuraGain and the Laryngeal Mask Airway (LMA) Supreme.
Interventions
- DEVICE Ambu AuraGain (size 1.5 or size 2.0)
- DEVICE LMA Supreme (size 1.5 or size 2.0)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2015-03 |
| Est. Completion | 2015-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02380768
The ClinicalTrials.gov registry entry for NCT02380768 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ann & Robert H Lurie Children's Hospital of Chicago, which has 159 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Ambu AuraGain (size 1.5 or size 2.0) is the first listed.
NCT02380768 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02380768 about?
NCT02380768 is a clinical study titled "A Comparison of the Ambu AuraGain Versus LMA Supreme in Children". The purpose of this study is to determine whether there is a clinically relevant difference in airway leak pressures between the Ambu AuraGain and the Laryngeal Mask Airway (LMA) Supreme.
What is the current status of trial NCT02380768?
This trial is currently completed. It is a NA study. The enrollment target is 100 participants. The study started on 2015-03. Estimated completion is 2015-06.
What interventions are being tested in trial NCT02380768?
The interventions under investigation include: Ambu AuraGain (size 1.5 or size 2.0) (DEVICE), LMA Supreme (size 1.5 or size 2.0) (DEVICE).
Who is sponsoring clinical trial NCT02380768?
This trial is sponsored by Ann & Robert H Lurie Children's Hospital of Chicago, which has 159 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.